Ball and socket implants for correction of hammer toes and claw toes

Information

  • Patent Grant
  • 10278828
  • Patent Number
    10,278,828
  • Date Filed
    Friday, October 28, 2016
    7 years ago
  • Date Issued
    Tuesday, May 7, 2019
    5 years ago
Abstract
A toe bone implant for correction of toe bone deformities is provided. The toe bone implant includes a first portion having a socket portion. The toe bone implant also includes a second portion having a ball portion operatively connected to the socket portion. The toe bone implant is implanted in a joint such that the ball portion is configured to rotate a predetermined amount respective to the socket portion.
Description
FIELD

The disclosed devices and methods generally relates to hammer toe and claw toe correction implants and devices.


BACKGROUND

A hammer toe or contracted toe is a deformity of the proximal inter-phalangeal joint of the second, third, or fourth toe causing it to be permanently bent and giving it a semblance of a hammer. Initially, the hammer toes are flexible and may be corrected with simple measures but, if left untreated, they get fixed and require surgical intervention for correcting them. People with hammer toe can have corns or calluses on the top of the middle joint of the toe or on the tip of the toe. They can also feel pain in their toes or feet and have difficulty in finding comfortable shoes. A claw toe is a typically a deformity of the metatarsal phalangeal joint of the second, third, fourth, or fifth toe causing unopposed flexion of the proximal inter-phalangeal joint and distal inter-phalangeal joint in the respective toe and giving it a semblance of a claw.


Various treatment strategies are available for correcting hammer toes and claw toes. First line treatment of hammer toes starts with new shoes that have soft and spacious toe boxes. Some toe exercises may also be prescribed, to stretch and strengthen the muscles. For example, gently stretching the toes manually, using the toes to pick up things off the floor etc. Another line of treatment includes using straps, cushions or non-medicated corn pads to relieve symptoms. Further, a hammer toe or claw toe can be corrected by a surgery if the other treatment options fail. Surgery can involve inserting screws, wires etc. or other similar implants in toes to straighten them.


Traditional surgical methods include use of k-wires. But of late, due to various disadvantages of using K-wires, compression screws are being used as an implant. K-wires require pings protruding through end of toes because they are temporarily inserted. Because of this, k-wires lead to pin tract infections, loss of fixation etc. Other disadvantages of k-wires include migration of k-wires and breakage, and may therefore require multiple surgeries.


Accordingly, there remains a need for developing improved toe bone implants and methods of correcting toe bone deformities.





BRIEF DESCRIPTION OF THE DRAWINGS

Various aspects of the present disclosure will be or become apparent to one with skill in the art by reference to the following detailed description when considered in connection with the accompanying exemplary non-limiting embodiments.



FIG. 1A is a side elevational view, partially in phantom, of a hammertoe implant formed in accordance with one embodiment of the invention;



FIG. 1B is a perspective exploded view of the hammertoe implant shown in FIG. 1A;



FIG. 1C is a side elevational view, partially in phantom, of the hammertoe implant shown in FIG. 1A;



FIG. 1D is a perspective view of a hammertoe implant assembled in accordance with another embodiment of the invention;



FIG. 1E is a side elevational view, partially in phantom, of a hammertoe implant including threaded portions;



FIG. 1F is a side elevational view of a further embodiment of hammertoe implant formed in accordance with the another embodiment of the invention including a blade portion and a threaded portion;



FIG. 2A is a side elevational view of an alternative embodiment of hammertoe implant including a socket portion, having both spherical and cylindrical articulating surfaces;



FIG. 2B is a perspective view of the hammertoe implant shown in FIG. 2A;



FIG. 2C is a side elevational view, partially in phantom, of an assembled hammertoe implant in accordance with FIGS. 2A and 2B;



FIG. 2D is a perspective view of the hammertoe implant shown in FIG. 2C;



FIG. 2E is a side elevational view, partially in phantom, of a hammertoe implant in accordance with FIG. 2A, including with threaded portions;



FIG. 2F is a side elevational view, partially in phantom, of a hammertoe implant in accordance with the embodiment of FIG. 2A, having blade portions;



FIG. 3A is a side elevational, partially exploded, and partially in phantom further embodiment of a hammertoe implant formed in accordance with the invention having spherical and cylindrical articulating surfaces;



FIG. 3B is a perspective view, partially exploded, of the hammertoe implant shown in FIG. 3A;



FIG. 3C is a side elevational view, partially in phantom, of an assembled hammertoe implant in accordance with FIGS. 3A and 3B;



FIG. 3D is a perspective view of the hammertoe implant shown in FIG. 3C;



FIG. 3E is a side elevational view, partially in phantom, of the hammertoe implant shown in FIGS. 3A-3D including threaded portions;



FIG. 3F is a side elevational view, partially in phantom, of the hammertoe implant shown in FIGS. 3A-3D, and including blade portions;



FIG. 4A is an exploded side elevational view, partially in phantom, of a further alternative embodiment of hammertoe implant including a cylindrical articulating surface and corresponding ball portion;



FIG. 4B is a perspective view of the hammertoe implant shown in FIG. 4A;



FIG. 4C is a side elevational view, partially in phantom, of the hammertoe implant shown in FIGS. 4A and 4B;



FIG. 4D is a perspective view of the hammertoe implant shown in FIG. 4C;



FIG. 4E is a side elevational view, partially in phantom, of a hammertoe implant in accordance with FIG. 4A showing a threaded portion and a blade portion;



FIG. 5A is a side elevational view, partially in phantom, of a further alternative embodiment of hammertoe implant including a ball portion and a socket portion that together accommodate a cross pin;



FIG. 5B is a perspective view of the hammertoe implant shown in FIG. 5A;



FIG. 5C is a side elevational view, partially in phantom, of the hammertoe implant of FIGS. 5A and 5B including a cross pin shown in phantom;



FIG. 5D is a side elevational view, partially in phantom, of the hammertoe implant shown in FIG. 5C but rotated 90° about axis X;



FIG. 6A is a side elevational view, partially in phantom, of yet a further alternative embodiment of hammertoe implant formed in accordance with the invention showing a flange portion included in a socket portion to limit rotation of a ball portion;



FIG. 6B is a perspective view of a hammertoe implant shown in FIG. 6A;



FIG. 6C is a side elevational view, partially in phantom, of an assembled hammertoe implant in accordance with FIGS. 6A and 6B;



FIG. 6D is a perspective view of the hammertoe implant shown in FIG. 6C;



FIG. 6E is a side elevational view, partially in phantom, of the hammertoe implant shown in FIGS. 6A-6D with the ball portion rotated within the socket portion at an angle relative to axes X and Y;



FIG. 6F is a perspective view of the hammertoe implant shown in FIG. 6E;



FIG. 6G is a side elevational view, partially in phantom, of a hammertoe implant shown in FIGS. 6A-6F, showing threaded portions;



FIG. 6H is a side elevational view, partially in phantom, of the hammertoe implant of FIGS. 6A-6F but including a threaded portion and a blade portion.



FIG. 7 is a flow chart illustrating a method of correcting a toe bone deformity according to embodiments of the present disclosure.



FIG. 8 is a further flow chart illustrating a method for correcting a bone joint according to one embodiment of the invention.





DETAILED DESCRIPTION

With reference to the Figures, where like elements have been given like numerical designations to facilitate an understanding of the drawings, the various embodiments of cyclic deposition and etch methods are described. The figures are not drawn to scale.


The following description is provided as an enabling teaching of a representative set of examples. Many changes can be made to the embodiments described herein while still obtaining beneficial results. Some of the desired benefits discussed below can be obtained by selecting some of the features or steps discussed herein without utilizing other features or steps. Accordingly, many modifications and adaptations, as well as subsets of the features and steps described herein are possible and can even be desirable in certain circumstances. Thus, the following description is provided as illustrative and is not limiting.


This description of illustrative embodiments is intended to be read in connection with the accompanying drawings, which are to be considered part of the entire written description. In the description of embodiments disclosed herein, any reference to direction or orientation is merely intended for convenience of description and is not intended in any way to limit the scope of the present disclosure. Relative terms such as “lower,” “upper,” “horizontal,” “vertical,”, “above,” “below,” “up,” “down,” “top” and “bottom” as well as derivative thereof (e.g., “horizontally,” “downwardly,” “upwardly,” etc.) should be construed to refer to the orientation as then described or as shown in the drawing under discussion. Terms such as “longitudinal” and “lateral” are to be interpreted relative to one another or relative to an axis of elongation, or an axis or center of rotation, as appropriate. These relative terms are for convenience of description only and do not require that the apparatus be constructed or operated in a particular orientation. Terms such as “attached,” “affixed,” “connected” and “interconnected,” refer to a relationship wherein structures are secured or attached to one another either directly or indirectly through intervening structures, as well as both movable or rigid attachments or relationships, unless expressly described otherwise. The term “operatively connected” is such an attachment, coupling or connection that allows the pertinent structures to operate as intended by virtue of that relationship. The term “adjacent” as used herein to describe the relationship between structures/components includes both direct contact between the respective structures/components referenced and the presence of other intervening structures/components between respective structures/components. When only a single machine is illustrated, the term “machine” shall also be taken to include any collection of machines that individually or jointly execute a set (or multiple sets) of instructions to perform any one or more of the methodologies discussed herein. In the claims, means-plus-function clauses, if used, are intended to cover the structures described, suggested, or rendered obvious by the written description or drawings for performing the recited function, including not only structural equivalents but also equivalent structures. The terms “implant” and “device” are used interchangeably in this disclosure and such use should not limit the scope of the claims appended herewith.


As used herein, use of a singular article such as “a,” “an” and “the” is not intended to exclude pluralities of the article's object unless the context clearly and unambiguously dictates otherwise.


Improved implants for hammer toe and/or claw toe correction are provided. Embodiments of the present subject matter provide a surgeon with a non-rigid construct and fusion of a joint after correction and a period of post-operative healing. Some embodiments can provide a rigid construct for initial post-operative wound healing and soft tissue release/relaxation while permitting predetermined motion back to the joint following a period of initial post-operative healing. Some embodiments can feature a proximal end of an implant including a ball portion and a distal end of the implant including a socket portion. A ball portion can include a portion of the implant having a surface of a suitable shape, including, but not limited to, a spherical, oval, cylindrical, or ellipsoidal shape, and permitting a predetermined movement of the ball portion when operatively connected to the socket portion. The inventors have observed that an implant having a ball portion and a socket portion can provide improved flexibility, stretching and movement at a respective joint post-insertion.



FIG. 1A illustrates a front plan view of a toe bone implant according to some embodiments of the present disclosure. FIG. 1B illustrates a perspective view of a toe bone implant according to some embodiments of the present disclosure. With reference to FIGS. 1A and 1B, an implant 100 for correcting hammertoes can include a first portion 130 and a second portion 110. In the illustrated embodiment, the first portion 130 includes a socket portion 140 disposed at an edge of the first portion 130. The socket portion 140 can be formed of any suitable material. For example, the socket portion 140 can be formed of a polyethylene material. In some embodiments, a socket portion 140 material is selected to permit flexibility in the socket portion 140. In some embodiments, the socket portion 140 can be formed of a first material and the remainder of the first portion 130 can be formed of a second material. For example, the socket portion 140 can be formed of a polyethylene material and the remainder of the first portion 130 can be formed of a second material such as, for example, stainless steel, titanium, or other metals or rigid polymers.


As shown in FIGS. 1A and 1B, the second portion 110 can include a ball portion 120. Ball portion 120 can be formed of any suitable material. For example, ball portion 120 can be formed of a material such as stainless steel, titanium, or other metals or rigid polymers. In some embodiments, the second portion 110, including ball portion 120, can be formed of the same material. In other embodiments, the ball portion 120 can be formed of a first material and the remainder of the second portion 110 can be formed of a second material. In the illustrated embodiment, socket portion 140 can be configured to receive ball portion 120. In some embodiments, socket portion 140 and ball portion 120 include respective articulating surfaces 145, 125 such that ball portion 120 is configured to move a predetermined amount respective to the socket portion 140 when operatively connected to the socket portion 140. For example, socket portion 140 and ball portion 120 can include respective articulating surfaces 145, 125 such that ball portion 120 is configured to rotate a predetermined amount about an axis of rotation respective to the socket portion 140 when operatively connected to the socket portion 140. Ball portion 120 and socket portion 140 can be formed of any suitable shape. For example, a ball portion 120 can include an articulating surface 125 of a suitable shape, including, but not limited to, a spherical, oval, cylindrical, or ellipsoidal shape, and permitting a predetermined movement of the ball portion 120 when operatively connected to the socket portion 140. Socket portion 140 can include an articulating surface 145 of a suitable shape such as, for example, a spherical, oval, cylindrical, or ellipsoidal shape, such that ball portion 120 is configured to move a predetermined amount respective to the socket portion 140 when operatively connected to the socket portion 140.



FIGS. 1A and 1B illustrate a toe bone implant 100 prior to operatively connecting the ball portion 120 and the socket portion 140. In the illustrated embodiment, toe bone implant 100 is shown prior to insertion into a joint. Toe bone implant 100 can include an edge portion 135 of first portion 130 and an edge portion 115 of second portion 110. As shown, respective edge portions 135, 115 are on opposing edges of the socket portion 140 of first portion 130 and ball portion 120 of second portion 110. In some embodiments (not shown), implant 100 can include a resorbable portion operatively connected to the first 130 and second 110 portions and configured to limit the rotation of the ball portion 120 respective to the socket portion 140 for a predetermined period of time. Any suitable resorbable device can be used. For example, a resorbable pin, bridge, or lock out device can be used to limit the rotation of the ball portion 120 respective to the socket portion 140 for a predetermined period of time. Any suitable resorbable material can be used to form the resorbable portion. For example, a bioresorbable material including, but not limited to, polylactide (PLA), poly-L-lactide (PLLA), polyglycolide (PGA), co-polymers of PLA and PGA including PGLA, poly-DL-lactide (PDLLA), co-polymers thereof, or other suitable bioabsorble polymers, biopolymers or biodegradable polymers can be used to form the resorbable portion. In some embodiments, a resorbable snap on, lock out device can be used to hold the implant 100 in a predetermined initial position for a predetermined period of time. In some embodiments, a resorbable bridge that could cross a joint where the implant was inserted can be used to hold the implant 100 in a predetermined initial position for a predetermined period of time. In some embodiments, the predetermined period of time is an initial healing period. For example, an initial healing period could be approximately six weeks (e.g. 5-7 weeks). In some embodiments the predetermined period of time can be a period between approximately 8-12 weeks (e.g. 7-13 weeks). However, any suitable predetermined period of time can be used. The inventors have observed that an implant having rigid fixation for a predetermined period of time achieved through the use of a resorbable device, and after resorption, permitting a predetermined amount of rotation of a ball portion 120 of the implant 100 relative to the socket portion 140, can provide significant improvements to patients suffering from hammertoe or claw toe.


Referring now to FIGS. 1C and 1D, a front plan view and a perspective view of a toe bone implant 100 are respectively provided after operatively connecting the ball portion 120 and the socket portion 140. In the illustrated embodiment, toe bone implant 100 is shown prior to insertion into a joint. In some embodiments, ball portion 120 can be configured to rotate a predetermined amount respective to socket portion 140 in a lateral direction (x). In some embodiments, ball portion 120 can be configured to rotate a predetermined amount respective to socket portion 140 about a lateral axis (x). In some embodiments, rotation in lateral direction (x) can be referred to as rotation in a plantar direction, e.g. toward the sole, i.e. at a substantially 90 degree angle between the front part of the foot and the shin. In some embodiments, ball portion 120 can be configured to rotate a predetermined amount respective to socket portion 140 in a longitudinal direction (y). In some embodiments, ball portion 120 can be configured to rotate a predetermined amount respective to socket portion 140 about a longitudinal axis (y). In some embodiments, rotation in longitudinal direction (y) can be referred to as rotation in a dorsal direction, e.g. toward or away from a shin bone. In some embodiments, ball portion 120 can be configured to rotate a predetermined amount respective to socket portion 140 in a longitudinal direction (y) and a lateral direction (x). In some embodiments, ball portion 120 can be configured to rotate a predetermined amount respective to socket portion 140 about a longitudinal axis (y) and a lateral axis (x). In the illustrated embodiment, ball portion 120 is configured to freely rotate respective to socket portion 140.


With reference to FIG. 1E, a front plan view of a toe bone implant 100 according to some embodiments is provided. As shown in FIG. 1E, a portion of first portion 130 and a portion of second portion 110 can be threaded 134, 114. The threads 134, 114 may be threaded in substantially the same direction or in opposing directions. As ball portion 120 is configured to freely rotate respective to socket portion 140, both the respective first 130 and second 110 portions can be threaded into a respective bone canal. As shown, the threaded portion 134, 114 of first 130 and second 110 portions can include a plurality of threads disposed along its respective length. The tip (not shown) of respective threaded portions 134, 114 can be pointed to facilitate the advancement of threads 134, 114 into a respective bone. The respective edge portions 135, 115 can have any suitable type of interfacing mechanism to accept a suitable implant drivers such as a screw head or the like. In some embodiments, the respective edge portions 135, 115 can include a female depression (not shown) adaptable to mate with a driver (not shown) having a male extension. In some embodiments, for example, the respective edge portions 135, 1151 can have a portion in the shape of a hex whereby a suitable driver has a corresponding hex adapter appropriate to drive the implant 100 into a respective bone.


Referring now to FIG. 1F, a front plan view of an implant 100 is shown according to some embodiments of the present disclosure. In the illustrated embodiment, a portion of first portion 130 includes blades 136 to improve alignment or implantation while inserting the first portion 130 into a bone canal. As shown, blade portion 136 includes a plurality of serrated edges on its top and bottom sides. In some embodiments, blade portion 136 can have a width that is greater than its thickness and can taper to a point. In some embodiments such as embodiments using a resorbable pin, a portion of first portion 130 can include blades 136 to improve alignment or implantation while inserting the first portion 130 into a bone canal. In some embodiments (not shown), a portion of first portion 130 can include barbs 136 to improve alignment or implantation while inserting the first portion 130 into a bone canal.


In various embodiments, an implant 100 can be implanted into targeted bones by any suitable method. For example, an implant 100 can be implanted or installed via a retrograde approach between, for example, proximate and middle phalanxes in a foot. One skilled in the art will understand that the method described herein may be applied to the middle and distal phalanxes, respective metatarsals, as well or other adjacent bones. In some embodiments, an implant 100 can be implanted via a retrograde approach between, for example, a phalanx and a metatarsal in a foot. In some embodiments, a driver can be used to implant an implant 100 into a joint. For example, a driver can be an elongated instrument and include one end having an adaptable portion suitable for mating with an implant 100 described above. In some embodiments, the adaptable portion can include a male hexagonal head adaptable to mate to a corresponding female depression in an edge portion 135, 115 of an implant 100. In some embodiments, an opposing end of the driver can include a driving pin or trocar and can include a flat modular section configured to accept a handle or other suitable mechanism to assist a surgeon during installation of an implant 100.


Referring now to FIG. 7, a flow chart showing a method of correcting a toe bone deformity is provided. At block 710, a joint is exposed between first and second bones. In some embodiments, the joint is a proximal interphalangeal (PIP) joint. In some embodiments, the joint is a distal interphalangeal (DIP) joint. In some embodiments, the joint is a metatarsal phalangeal joint. In some embodiments, a toe can be opened to provide access to a joint between a first bone and a second bone. For example, a toe can be opened to provide access to a joint between a middle phalanx and a proximal phalanx, or, for example, between a distal phalanx and a proximal metatarsal. In some embodiments, an incision is made to open the joint. In some embodiments, the first and/or second bones, respectively, may be resected using a bone saw or other tool, if necessary. The resected surfaces of the first and/or second bones can be debrided if necessary. At block 720, bone implant 100 can be inserted into the joint. Any suitable insertion method can be used. At block 730, an edge portion 135, 115 of respective first 130 and second 110 implant portions is inserted into respective first and second bones. Any suitable method to insert the respective edge portions 115, 135 into first and second bones. For example, an intermedullary canal can be drilled into one or both of the first and second bones using a drill or other mechanism to an appropriate depth. In some embodiments, a reamer can be used for precise and accurate canal drilling. In some embodiments, a driver can be engaged with an edge portion 135 of the first portion 130 of an implant 100 as described above, and an edge portion 115 of the second portion 110 of the implant 100 can be threaded into the first bone. In some embodiments, bladed portion 136 of first portion 130 can be disposed within a slot of a driving adapter and the body of the driving adapter can be secured in a chuck of a drill or other driving instrument. A drill or other driving instrument can be used to drive threaded portion 114 of second portion 110 into a surface of a second bone, for example, a proximal metatarsal. With the threaded portion 114 of second portion 110 of implant 100 disposed within second bone, a driving adapter can be disengaged from blade portion 136 of first portion 130 of implant 100.


The first bone, for example a distal phalanx, can be predrilled or broached using a drill, or other suitable device, to create a hole. In some embodiments, a reamer can be used for precise drilling or broaching. The predrilled or broached first bone is then repositioned such that the predrilled hole or broach aligns with the blade portion 136 of first portion 130 of implant 100. The first bone is then pressed into engagement with the blade portion 136 of first portion 130. The serrated edges of blade portion 136 of first portion 130 help to maintain engagement between first bone and blade portion 136 of first portion 130 of implant 100. In some embodiments, a ball portion 120 of second portion 110 can be operatively connected to a socket portion 140 of first portion 130 in situ. In some embodiments, a ball portion 120 of second portion 110 can be operatively connected to a socket portion 140 of first portion 130 prior to insertion of toe implant 100 into the joint. At block 740, the ball portion 120 is aligned with socket portion 140 such that ball portion 120 is configured to rotate a predetermined amount relative to socket portion 140. In some embodiments (e.g. FIGS. 2, 3, 4, 6), a ball portion of a second portion can be operatively connected to a socket portion of a first portion in situ. In some embodiments, the respective edge portions of ball portion 120 of second portion 110 and socket portion 140 of first portion 130 are inserted into respective first and second bones such that the ball portion 120 is aligned with socket portion 140 and is configured to rotate a predetermined amount relative to the socket portion 140.


With reference now to FIGS. 2A-2F, various plan and perspective views of an implant 200 according to some embodiments of the present disclosures are provided. In the illustrated embodiment, the first portion 230 and second portion 210 can be inserted (720) into a joint independent of each other. The ball portion 220 can be operatively connected to the socket portion 240 in situ. As shown and described above, socket portion 240 is formed of a material flexible enough to allow insertion and operative connection of the ball portion 220 of second portion 210. In some embodiments, the force required to insert ball portion 220 into socket portion 240 is less than the force required to remove ball portion 220 from socket portion 240. As shown in FIGS. 2B-2F, ball portion 220 will not detach from socket portion 240. With reference now to FIGS. 2B and 2D, both spherical 225, 245 and cylindrical 242 articulating surfaces can be provided on the ball portion 220 and socket portion 240 to limit the rotation of the ball portion 220 relative to the socket portion 240 to dorsi/plantar flexion. In some embodiments, where the predetermined amount of rotation of the ball portion 220 relative to socket portion 240 is limited to dorsiflexion, a greater amount of material can be added to the plantar portion of socket portion 240 of the first portion 230 of implant 200.


In some embodiments, an open procedure can be used to expose a joint (710), for inserting the implant 200 into the joint, and for soft tissue release. As discussed above, first and second bones can be resected in some embodiments. In some embodiments, a reamer can be used to for accurate and precise drilling of a canal into respective first and second bones. As shown in FIG. 2E, first 230 and second 210 portions can include respective threaded portions 234, 214. In some embodiments, respective edge portions 235, 215 can be threaded into canals as described above (715) as the first 230 and second 210 portions are implanted independently and operatively connected in situ. As shown in FIG. 2F, first 230 and second 210 portions can include respective bladed portion 236, 216. In some embodiments, respective edge portions 235, 215 can be inserted into respective first and second bones independently and ball portion 220 inserted into and operatively connected to socket portion 240 in situ to align ball portion 220 with socket portion 240 and configure it to rotate a predetermined amount relative to socket portion 240. In some embodiments (not shown), implant 200 can include a resorbable portion operatively connected to the first 230 and second 210 portions and configured to limit the rotation of the ball portion 220 respective to the socket portion 240 for a predetermined period of time as described above.


Referring now to FIGS. 3A-3F, various plan and perspective views of implant 300 are provided according to some embodiments of the present disclosure. As shown in FIGS. 3B and 3D, both spherical 325, 345 and cylindrical 342 articulating surfaces can be provided on the ball portion 320 and socket portion 340 to limit the rotation of the ball portion 320 relative to the socket portion 340 to dorsi/plantar flexion. In some embodiments, where the predetermined amount of rotation of the ball portion 320 relative to socket portion 340 is limited to dorsiflexion, a greater amount of material can be added to the plantar portion of socket portion 340 of the first portion 330 of implant 300. As shown in the illustrated embodiments of 2B, 2D, 3B and 3D, there is less dorsal/plantar constraint in the embodiments illustrated in FIGS. 3B and 3D and more dorsal/plantar constraint in the embodiments shown in FIGS. 2B and 2D.


In some embodiments, an open procedure can be used to expose a joint (710), for inserting the implant 300 into the joint, and for soft tissue release. As discussed above, first and second bones can be resected in some embodiments. In some embodiments, a reamer can be used to for accurate and precise drilling of a canal into respective first and second bones. As shown in FIG. 3E, first 330 and second 310 portions can include respective threaded portions 334, 314. In some embodiments, respective edge portions 335, 315 can be threaded into canals as described above (715) as the first 330 and second 310 portions are implanted independently and operatively connected in situ. As shown in FIG. 2F, first 330 and second 310 portions can include respective bladed portion 336, 316. In some embodiments, respective edge portions 335, 315 can be inserted into respective first and second bones independently and ball portion 320 inserted into and operatively connected to socket portion 340 in situ to align ball portion 320 with socket portion 340 and configure it to rotate a predetermined amount relative to socket portion 340. In some embodiments (not shown), implant 300 can include a resorbable portion operatively connected to the first 330 and second 310 portions and configured to limit the rotation of the ball portion 320 respective to the socket portion 340 for a predetermined period of time as described above.


Referring now to FIGS. 4A-4E, various plan and perspective views of an implant 400 are provided according to some embodiments of the present disclosure. As illustrated in FIGS. 4A and 4C, ball portion 420 and socket portion 440 can include respective cylindrical articulating surfaces 427, 447 and respective spherical articulating surfaces 445, 425 to limit the rotation of the ball portion 420 relative to the socket portion 440 to a predetermined amount. In the illustrated embodiment, interior portion 450 formed in socket portion 440 along with respective cylindrical articulating surfaces 427, 447 and respective spherical articulating surfaces 445, 425 creates a hinge type of implant 400 and limits rotation of the ball portion 420 relative to socket portion 440 to dorsal/plantar flexion. In some embodiments, where the predetermined amount of rotation of the ball portion 420 relative to socket portion 440 is limited to dorsiflexion, a greater amount of material can be added to the plantar portion of socket portion 440 of the first portion 430 of implant 400.


In some embodiments, an open procedure can be used to expose a joint (710), for inserting the implant 400 into the joint, and for soft tissue release. As discussed above, first and second bones can be resected in some embodiments. In some embodiments, a reamer can be used to for accurate and precise drilling of a canal into respective first and second bones. In some embodiments (not shown), first 430 and second 410 portions can include respective threaded portions (not shown). In some embodiments (not shown), respective edge portions 435, 415 can be threaded into canals as described above (715) as the first 430 and second 410 portions are implanted independently and operatively connected in situ. As shown in FIG. 4E, in some embodiments, first portion 430 can include a bladed portion 436 and second portion 410 can include a threaded portion 414 and respective edge portions 435, 415 can be threaded into canals as described above (715) as the first 430 and second 410 portions are implanted independently and operatively connected in situ. In some embodiments (not shown), first 430 and second 310 portions can include respective bladed portions. In some embodiments (not shown), first 430 and second 310 portions can include respective barbed portions. In some embodiments, respective edge portions 435, 415 can be inserted into respective first and second bones independently and ball portion 420 inserted into and operatively connected to socket portion 440 in situ to align ball portion 420 with socket portion 440 and configure it to rotate a predetermined amount relative to socket portion 440. In some embodiments (not shown), implant 400 can include a resorbable portion operatively connected to the first 430 and second 410 portions and configured to limit the rotation of the ball portion 420 respective to the socket portion 440 for a predetermined period of time as described above.


Referring now to FIGS. 5A-5D, various plan and perspective views of a hinge type bone implant 500 according to some embodiments of the present disclosure are provided. In the illustrated embodiments, the ball portion 520 is inserted into the socket portion 540 prior to inserting the bone implant 500 into a joint (720). As shown in the illustrated embodiment, a cross pin 560 can be inserted between the ball portion 520 and the socket portion 540 to limit rotation of the ball portion 520 relative to the socket portion 540 to dorsi/plantar flexion. In some embodiments, the ball portion 520 can be disposed asymmetrically relative to the socket portion 540 to further limit rotation to a predetermined amount. In some embodiments, and as shown in FIG. 5C, resorbable cross-pin ends 565 can be included to restrict rotation of the ball portion 520 relative to the socket portion 520 for a predetermined period of time as described above. In some embodiments, where the predetermined amount of rotation of the ball portion 520 relative to socket portion 540 is limited to dorsiflexion, a greater amount of material can be added to the plantar portion of socket portion 540 of the first portion 530 of implant 500.


In some embodiments, an open procedure can be used to expose a joint (710), for inserting the implant 500 into the joint, and for soft tissue release. As discussed above, first and second bones can be resected in some embodiments. In some embodiments, a reamer can be used to for accurate and precise drilling of a canal into respective first and second bones. In some embodiments (not shown), one of the first 530 or second 510 portions can include a respective threaded portions (not shown) as the implant 500 is assembled prior to insertion into a joint. In some embodiments (not shown), the respective edge portion 435 (or 415) of the respective portion including a threaded portion can be threaded into a respective canal as described above (715). In some embodiments, the other one of the first 530 or second 510 portions of the implant 500 can include a bladed portion. In some embodiments, the other one of the first 530 or second 510 portions of the implant 500 can include a barbed portion.


With reference now to FIGS. 6A-6H, various plan and perspective views of an implant 600 according to some embodiments of the present disclosure are provided. In the illustrated embodiments, a flange portion 670 is included in socket portion 640 to limit the rotation of the ball portion 620 relative to socket portion 640 in the plantar flexion direction. As shown in FIGS. 6E and 6F, ball portion 620 can be disposed asymmetrically relative to socket portion 640 to further limit the rotation of the ball portion 620 relative to socket portion 640 in the plantar flexion direction. As shown in the illustrated embodiment, ball portion 620 and socket portion 640 include respective spherical articulating surfaces which provide rotation of the ball portion 620 a predetermined amount relative to the socket portion 640.


As shown in FIG. 6G, in embodiments where the implant 600 is assembled in situ, first portion 630 and second portion 610 can include respective threaded portion 634, 614. In embodiments where the implant 600 in assembled prior to insertion into the joint (at block 720), one of the first 630 or second 610 portions can include a respective threaded portion (e.g. FIG. 6H and threaded portion 614) and the other one of the first 630 or second 610 portions of the implant 600 can include a bladed portion (e.g. FIG. 6H and threaded portion 616). In some embodiments, the other one of the first 630 or second 610 portions of the implant 600 can include a barbed portion (not shown). In some embodiments (not shown), implant 600 can include a resorbable portion operatively connected to the first 630 and second 610 portions and configured to limit the rotation of the ball portion 620 respective to the socket portion 640 for a predetermined period of time as described above. In embodiments having a resorbable portion, a barbed or bladed portion can be included on the portion of the implant 600 configured for insertion into the distal bone for improved alignment and implantation.


Referring now to FIG. 8, a flow chart showing a method of correcting a toe bone deformity is provided. At block 810, a joint is exposed between first and second bones as described above for block 710. In some embodiments, the joint is a proximal interphalangeal (PIP) joint. In some embodiments, the joint is a distal interphalangeal (DIP) joint. In some embodiments, the joint is a metatarsal phalangeal joint. At block 820, bone implant 100 (200, 300, 400, 500, 600) can be inserted into the joint as described above for block 720. At block 830, an edge portion of the respective first 130 (230, 330, 430, 530, 630) and second 110 (210, 310, 410, 510, 610) portions is inserted into the respective first and second bones as described above for block 730. At block 840, a ball portion 120 (220, 320, 420, 520, 620) of the second portion 110 (210, 310, 410, 510, 610) can be aligned with a socket portion 140 (240, 340, 440, 540, 640) of the first portion 130 (230, 330, 430, 530, 630) such that the ball portion 120 (220, 320, 420, 520, 620) is configured to rotate a predetermined amount relative to the socket portion 140 (240, 340, 440, 540, 640) In some embodiments, a ball portion 220 (320, 420, 620) of second portion 210 (310, 410, 610) can be operatively connected to a socket portion 240 (340, 440, 640) of first portion 230 (330, 430, 630) in situ. In some embodiments, a ball portion 120 (520, 620) of second portion 110 (510, 610) can be operatively connected to a socket portion 140 (540, 640) of first portion 130 (530, 630) prior to inserting the bone implant 100 (500, 600) into a joint (820). In some embodiments, the respective edge portions of ball portion 120 (220, 320, 420, 520, 620) of second portion 110 (210, 310, 410, 510, 610) and socket portion 140 (240, 340, 440, 540, 640) of first portion 130 (230, 330, 430, 530, 630) are inserted into respective first and second bones such that the ball portion 120 (220, 320, 420, 520, 620) is aligned with socket portion 140 (240, 340, 440, 540, 640) and is configured to rotate a predetermined amount relative to the socket portion 140 (240, 340, 440, 540, 640).


Although reference has been made to a patient's proximal and distal interphalangeal joints and metatarsal phalangeal joints, one skilled in the art will understand that embodiments of the present disclosure may be implemented for other respective bones including, but not limited to other phalanges/digits and phalangeal/digital joints.


It may be emphasized that the above-described and illustrated embodiments are merely possible examples of implementations and merely set forth for a clear understanding of the principles of the disclosure. Many variations and modifications may be made to the above-described embodiments of the disclosure without departing substantially from the spirit and principles of the disclosure. All such modifications and variations are intended to be included herein within the scope of this disclosure and the present disclosure and protected by the following claims.


While this specification contains many specifics, these should not be construed as limitations on the scope of the claimed subject matter, but rather as descriptions of features that may be specific to particular embodiments. Certain features that are described in this specification in the context of separate embodiments can also be implemented in combination in a single embodiment. Conversely, various features that are described in the context of a single embodiment can also be implemented in multiple embodiments separately or in any suitable sub-combination. Moreover, although features may be described above as acting in certain combinations and even initially claimed as such, one or more features from a claimed combination can in some cases be excised from the combination, and the claimed combination may be directed to a sub-combination or variation of a sub-combination.


As shown by the various configurations and embodiments illustrated in FIGS. 1A-8, improved toe bone implants and methods of correcting toe bone deformities have been described.


Some embodiments provide a toe bone implant. The toe bone implant includes a first portion having a socket portion. The toe bone implant also includes a second portion having a ball portion operatively connected to the socket portion. The toe bone implant is implanted in a joint such that the ball portion is configured to rotate a predetermined amount respective to the socket portion.


Some embodiments provide a method of correcting a toe bone deformity. The method includes exposing a joint between first and second bones and inserting a bone implant into the joint. The bone implant includes a first portion including a socket portion and a second portion including a ball portion operatively connected to the socket portion. The method includes inserting an edge portion of the respective first and second portions into the respective first and second bones, and aligning the ball portion with the socket portion such that the ball portion is configured to rotate a predetermined amount relative to the socket portion.


Some embodiments provide a toe bone implant. The toe bone implant includes a first portion having a socket portion. The toe bone implant includes a second portion having a ball portion operatively connected to the socket portion such that the ball portion is configured to rotate a predetermined amount respective to the socket portion. The toe bone implant also includes a resorbable portion operatively connected to the first and second portions and configured to limit rotation of the ball portion respective to the socket portion for a predetermined period of time.


While various embodiments are described herein, it is to be understood that the embodiments described are illustrative only and that the scope of the subject matter is to be accorded a full range of equivalents, many variations and modifications naturally occurring to those of skill in the art from a perusal hereof.

Claims
  • 1. A joint implant, comprising: a first portion and a second portion wherein the first portion is operatively connected to the second portion so as to rotate a predetermined amount with respect to the first portion; and a resorbable portion selected from the group consisting of a resorbable pin, a resorbable bridge, a resorbable lock out device, and a resorbable snap-on being operatively connected to the first and second portions and configured to limit said rotation for a predetermined period of time.
  • 2. The joint implant of claim 1, wherein the first portion is configured to rotate a predetermined amount in a longitudinal direction.
  • 3. The bone implant of claim 1, wherein the first portion is configured to rotate a predetermined amount in a lateral direction.
  • 4. The bone implant of claim 1, wherein the first portion is configured to freely rotate about an axis of rotation.
  • 5. The bone implant of claim 1, wherein the joint is a proximal interphalangeal (PIP) joint.
  • 6. The bone implant of claim 1, wherein the joint is a metatarsal phalangeal joint.
  • 7. The bone implant of claim 1, wherein one or more of the first or second portions comprises a threaded edge portion.
  • 8. The bone implant of claim 1, wherein one or more of the first or second portions comprises an edge portion comprising blades.
  • 9. A joint implant, comprising: a first portion and a second portion wherein the first portion is operatively connected to the second portion so as to rotate a predetermined amount with respective to the first portion; and a resorbable portion operatively connected to the first and second portions and configured to limit said rotation a predetermined period of time of approximately 8 to 12 weeks and when the implant is implanted in a joint.
CROSS REFERENCES

This application is a continuation of U.S. patent application Ser. No. 14/560,265, filed Dec. 4, 2014, which is a divisional of co-pending U.S. patent application Ser. No. 13/839,573, filed on Mar. 15, 2013, which claims priority of U.S. Provisional Patent Application Ser. No. 61/747,429, filed on Dec. 31, 2012, the entireties of which are incorporated herein by reference.

US Referenced Citations (494)
Number Name Date Kind
321389 Schirmer Jun 1885 A
346148 Durham Jul 1886 A
348589 Sloan Sep 1886 A
373074 Jones Nov 1887 A
430236 Rogers Jun 1890 A
561968 Coulon Jun 1896 A
736121 Lipscomb Aug 1903 A
821025 Davies May 1906 A
882937 Pegley Mar 1908 A
1966835 Stites Jul 1934 A
2140749 Kaplan Dec 1938 A
2361107 Johnson Oct 1944 A
2451747 Kindt Oct 1948 A
2490364 Livingston Dec 1949 A
2600517 Rushing Jun 1952 A
2697370 Brooks Dec 1954 A
2832245 Burrows Apr 1958 A
2895368 Place Jul 1959 A
3462765 Swanson Aug 1969 A
3466669 Flatt Sep 1969 A
3593342 Niebauer et al. Jul 1971 A
3681786 Lynch Aug 1972 A
3739403 Nicolle Jun 1973 A
3759257 Fischer et al. Sep 1973 A
3760802 Fischer et al. Sep 1973 A
3779239 Fischer et al. Dec 1973 A
3824631 Burstein et al. Jul 1974 A
D243716 Treace et al. Mar 1977 S
4047524 Hall Sep 1977 A
4096896 Engel Jun 1978 A
4156296 Johnson et al. May 1979 A
4170990 Baumgart et al. Oct 1979 A
4175555 Herbert Nov 1979 A
4198713 Swanson Apr 1980 A
4204284 Koeneman May 1980 A
4213208 Marne Jul 1980 A
4237875 Termanini Dec 1980 A
4262665 Roalstad et al. Apr 1981 A
4263903 Griggs Apr 1981 A
4275717 Bolesky Jun 1981 A
4276660 Laure Jul 1981 A
4278091 Borzone Jul 1981 A
4304011 Whelan, III Dec 1981 A
4321002 Froehlich Mar 1982 A
4364382 Mennen Dec 1982 A
4367562 Gauthier Jan 1983 A
4404874 Lieser Sep 1983 A
4434796 Karapetian et al. Mar 1984 A
4454875 Pratt et al. Jun 1984 A
4485816 Krumme Dec 1984 A
D277509 Lawrence et al. Feb 1985 S
D277784 Sgariato et al. Feb 1985 S
4516569 Evans et al. May 1985 A
4570623 Ellison et al. Feb 1986 A
4590928 Hunt et al. May 1986 A
D284099 Laporta et al. Jun 1986 S
4634382 Kusano et al. Jan 1987 A
4642122 Stefee Feb 1987 A
4655661 Brandt Apr 1987 A
D291731 Alkins Sep 1987 S
4723540 Gilmer, Jr. Feb 1988 A
4723541 Reese Feb 1988 A
4731087 Sculco et al. Mar 1988 A
4756711 Mai et al. Jul 1988 A
4759768 Hermann et al. Jul 1988 A
4790304 Rosenberg Dec 1988 A
4865606 Rehder Sep 1989 A
4908031 Frisch Mar 1990 A
4915092 Firica et al. Apr 1990 A
4932974 Pappas et al. Jun 1990 A
4940467 Tronzo Jul 1990 A
4955916 Carignan et al. Sep 1990 A
4963144 Huene Oct 1990 A
4969909 Barouk Nov 1990 A
5002563 Pyka et al. Mar 1991 A
5007932 Bekki et al. Apr 1991 A
5011497 Persson et al. Apr 1991 A
5019079 Ross May 1991 A
5029753 Hipon et al. Jul 1991 A
5037440 Koenig Aug 1991 A
5046513 Gatturna et al. Sep 1991 A
5047059 Saffar Sep 1991 A
5053038 Sheehan Oct 1991 A
5059193 Kuslich Oct 1991 A
5062851 Branemark Nov 1991 A
5089009 Green Feb 1992 A
5092896 Meuli et al. Mar 1992 A
5108395 Laurain Apr 1992 A
5133761 Krouskop Jul 1992 A
5147363 Harle Sep 1992 A
5171252 Friedland Dec 1992 A
5179915 Cohen et al. Jan 1993 A
5190546 Jervis Mar 1993 A
5199839 DeHaitre Apr 1993 A
5207712 Cohen May 1993 A
5209756 Seedhom et al. May 1993 A
5213347 Rulon et al. May 1993 A
5222975 Crainich Jun 1993 A
5246443 Mai Sep 1993 A
5281225 Vicenzi Jan 1994 A
5304204 Bregen Apr 1994 A
5324307 Jarrett et al. Jun 1994 A
5326364 Clift, Jr. et al. Jul 1994 A
5326366 Pascarella et al. Jul 1994 A
5330476 Hiot et al. Jul 1994 A
5342396 Cook Aug 1994 A
5352229 Goble et al. Oct 1994 A
5354301 Catellano Oct 1994 A
5358405 Imai Oct 1994 A
5360450 Giannini Nov 1994 A
5366479 McGarry et al. Nov 1994 A
5380334 Torrie et al. Jan 1995 A
5395372 Holt et al. Mar 1995 A
5405400 Linscheid et al. Apr 1995 A
5405401 Lippincott, III et al. Apr 1995 A
5417692 Goble et al. May 1995 A
5425776 Cohen Jun 1995 A
5425777 Sarkisian et al. Jun 1995 A
5437674 Worcel et al. Aug 1995 A
5449359 Groiso Sep 1995 A
5454814 Comte Oct 1995 A
5458648 Berman et al. Oct 1995 A
5470230 Daftary et al. Nov 1995 A
5474557 Mai Dec 1995 A
5480447 Skiba Jan 1996 A
5484443 Pascarella et al. Jan 1996 A
5498265 Asnis et al. Mar 1996 A
5507822 Bouchon et al. Apr 1996 A
5516248 DeHaitre May 1996 A
5522903 Sokolow et al. Jun 1996 A
5529075 Clark Jun 1996 A
5536127 Pennig Jul 1996 A
5549681 Segmüller et al. Aug 1996 A
5551871 Besselink et al. Sep 1996 A
5554157 Errico et al. Sep 1996 A
5578034 Estes Nov 1996 A
5591165 Jackson Jan 1997 A
5595563 Moisdon Jan 1997 A
5601558 Torrie et al. Feb 1997 A
D378409 Michelson Mar 1997 S
5634925 Urbanski Jun 1997 A
5643264 Sherman et al. Jul 1997 A
5645599 Samani Jul 1997 A
5660188 Groiso Aug 1997 A
5669913 Zobel Sep 1997 A
5674297 Lane et al. Oct 1997 A
5683466 Vitale Nov 1997 A
5690629 Asher et al. Nov 1997 A
5702472 Huebner Dec 1997 A
5707395 Li Jan 1998 A
5713903 Sander et al. Feb 1998 A
5713904 Errico et al. Feb 1998 A
5720753 Sander et al. Feb 1998 A
5725585 Zobel Mar 1998 A
5728127 Asher et al. Mar 1998 A
5733307 Dinsdale Mar 1998 A
5741256 Bresina Apr 1998 A
5749916 Richelsoph May 1998 A
5769852 Brånemark Jun 1998 A
5776202 Copf et al. Jul 1998 A
5779707 Bertholet et al. Jul 1998 A
5782927 Klawittler et al. Jul 1998 A
5785713 Jobe Jul 1998 A
5840078 Yerys Nov 1998 A
5853414 Groiso Dec 1998 A
5876434 Flomenblit et al. Mar 1999 A
5882444 Flomenblit et al. Mar 1999 A
5893850 Cachia Apr 1999 A
5919193 Slavitt Jul 1999 A
5928236 Augagneur et al. Jul 1999 A
5941890 Voegele et al. Aug 1999 A
5951288 Sawa Sep 1999 A
5958159 Prandi Sep 1999 A
5980524 Justin et al. Nov 1999 A
5984970 Bramlet Nov 1999 A
5984971 Faccioli et al. Nov 1999 A
6011497 Tsang et al. Jan 2000 A
6017366 Berman Jan 2000 A
6030162 Huebner Feb 2000 A
6045573 Wenstrom, Jr. et al. Apr 2000 A
6048151 Kwee Apr 2000 A
6048343 Mathis et al. Apr 2000 A
6083242 Cook Jul 2000 A
6099571 Knapp Aug 2000 A
6102642 Kawashita et al. Aug 2000 A
6146387 Trott et al. Nov 2000 A
6187009 Herzog et al. Feb 2001 B1
6193757 Foley et al. Feb 2001 B1
6197037 Hair Mar 2001 B1
6200321 Orbay et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6200345 Morgan Mar 2001 B1
6224600 Protogirou May 2001 B1
6248109 Stofella Jun 2001 B1
6299613 Ogilvie et al. Oct 2001 B1
6305053 Galbreath Oct 2001 B1
6306140 Siddiqui Oct 2001 B1
6319284 Rushdy et al. Nov 2001 B1
6332885 Martella Dec 2001 B1
6336928 Guerin et al. Jan 2002 B1
6352560 Poeschmann et al. Mar 2002 B1
6383223 Baehler et al. May 2002 B1
6386877 Sutter May 2002 B1
6406234 Frigg Jun 2002 B2
6413260 Berrevoets et al. Jul 2002 B1
6419706 Graf Jul 2002 B1
6423097 Rauscher Jul 2002 B2
6428634 Besselink et al. Aug 2002 B1
6436099 Drewry et al. Aug 2002 B1
6451057 Chen et al. Sep 2002 B1
6454808 Masada Sep 2002 B1
6458134 Songer et al. Oct 2002 B1
6475242 Bramlet Nov 2002 B1
6508841 Martin et al. Jan 2003 B2
6517543 Berrevoets et al. Feb 2003 B1
6533788 Orbay Mar 2003 B1
6551321 Burkinshaw Apr 2003 B1
6551343 Törmälä et al. Apr 2003 B1
6575973 Shekalim Jun 2003 B1
6575976 Grafton Jun 2003 B2
6582453 Tran et al. Jun 2003 B1
6648890 Culbert et al. Nov 2003 B2
6679668 Martin et al. Jan 2004 B2
6682565 Krishnan Jan 2004 B1
6685706 Padget et al. Feb 2004 B2
6699247 Zucherman et al. Mar 2004 B2
6699292 Ogilvie et al. Mar 2004 B2
6706045 Lin et al. Mar 2004 B2
6767350 Lob Jul 2004 B1
6773437 Ogilvie et al. Aug 2004 B2
6811568 Minamikawa Nov 2004 B2
6869449 Ball et al. Mar 2005 B2
6875235 Ferree Apr 2005 B2
7037309 Weil et al. May 2006 B2
7037324 Martinek May 2006 B2
7037342 Nilsson et al. May 2006 B2
7041106 Carver et al. May 2006 B1
7044953 Capanni May 2006 B2
7112214 Peterson et al. Sep 2006 B2
7182787 Hassler et al. Feb 2007 B2
7192445 Ellingsen et al. Mar 2007 B2
7207994 Vlahos et al. Apr 2007 B2
7240677 Fox Jul 2007 B2
7261716 Strobel Aug 2007 B2
7291175 Gordon Nov 2007 B1
7569061 Colleran Aug 2009 B2
7585316 Trieu Sep 2009 B2
7588603 Leonard Sep 2009 B2
7695471 Cheung et al. Apr 2010 B2
7708759 Lubbers et al. May 2010 B2
7727235 Contiliano et al. Jun 2010 B2
7780701 Meridew et al. Aug 2010 B1
7780737 Bonnard et al. Aug 2010 B2
7785357 Guan et al. Aug 2010 B2
7837738 Reigstad et al. Nov 2010 B2
7842091 Johnstone et al. Nov 2010 B2
7887589 Glenn et al. Feb 2011 B2
7909880 Grant Mar 2011 B1
7918879 Yeung et al. Apr 2011 B2
7959681 Lavi Jun 2011 B2
7963995 Richelsoph Jun 2011 B2
7976565 Meridew Jul 2011 B1
7985246 Trieu Jul 2011 B2
8002811 Corradi et al. Aug 2011 B2
8057524 Meridew Nov 2011 B2
8100983 Schulte Jan 2012 B2
8118839 Taylor Feb 2012 B2
8118849 Wahl et al. Feb 2012 B2
8197509 Contiliano et al. Jun 2012 B2
8262712 Coilard-Lavirotte et al. Sep 2012 B2
8267939 Cipoletti et al. Sep 2012 B2
8337537 Pelo et al. Dec 2012 B2
8394097 Peyrot et al. Mar 2013 B2
8394132 Lewis et al. Mar 2013 B2
8414583 Prandi et al. Apr 2013 B2
8465525 Hawkins et al. Jun 2013 B2
8475456 Augoyard et al. Jul 2013 B2
8523944 Jiminez et al. Sep 2013 B2
8591545 Lunn et al. Nov 2013 B2
8608785 Reed et al. Dec 2013 B2
8616091 Anderson Dec 2013 B2
8636457 Connors Jan 2014 B2
8641769 Malandain Feb 2014 B2
8647390 Bellemere et al. Feb 2014 B2
8764842 Graham Jul 2014 B2
8840677 Kale et al. Sep 2014 B2
8888779 Senn Nov 2014 B2
D720072 Cheney et al. Dec 2014 S
8906060 Hart Dec 2014 B2
8986386 Oglaza et al. Mar 2015 B2
8998999 Lewis et al. Apr 2015 B2
9044287 Reed et al. Jun 2015 B2
9056014 McCormick et al. Jun 2015 B2
9125704 Reed et al. Sep 2015 B2
9138274 Biesinger et al. Sep 2015 B1
9149268 Graul et al. Oct 2015 B2
9474561 Shemwell Oct 2016 B2
20010025199 Rauscher Sep 2001 A1
20010028836 Kohori Oct 2001 A1
20010049529 Cachia et al. Dec 2001 A1
20020019636 Ogilvie et al. Feb 2002 A1
20020022887 Huene Feb 2002 A1
20020026194 Morrison et al. Feb 2002 A1
20020055785 Harris May 2002 A1
20020065561 Ogilvie et al. May 2002 A1
20020068939 Levy et al. Jun 2002 A1
20020072803 Saunders et al. Jun 2002 A1
20020082705 Bouman et al. Jun 2002 A1
20020111690 Hyde Aug 2002 A1
20020128713 Ferree Sep 2002 A1
20020165544 Perren et al. Nov 2002 A1
20020183846 Kuslich et al. Dec 2002 A1
20030032961 Pelo et al. Feb 2003 A1
20030040805 Minamikawa Feb 2003 A1
20030069645 Ball et al. Apr 2003 A1
20030130660 Levy et al. Jul 2003 A1
20030191422 Sossong Oct 2003 A1
20030233095 Urbanski et al. Dec 2003 A1
20040010315 Song Jan 2004 A1
20040093081 Nilsson et al. May 2004 A1
20040097941 Weiner et al. May 2004 A1
20040102853 Boumann et al. May 2004 A1
20040111117 Colleran et al. Jun 2004 A1
20040133204 Davies Jul 2004 A1
20040138756 Reeder Jul 2004 A1
20040220574 Pelo et al. Nov 2004 A1
20040220678 Chow et al. Nov 2004 A1
20040230193 Cheung et al. Nov 2004 A1
20040230194 Urbanski et al. Nov 2004 A1
20040230313 Saunders Nov 2004 A1
20040249461 Ferree Dec 2004 A1
20050113836 Lozier et al. May 2005 A1
20050119757 Hassler et al. Jun 2005 A1
20050123672 Justin et al. Jun 2005 A1
20050124443 Summers Jun 2005 A1
20050149031 Ciccone et al. Jul 2005 A1
20050177158 Doubler et al. Aug 2005 A1
20050187636 Graham Aug 2005 A1
20050251265 Calandruccio et al. Nov 2005 A1
20050261768 Trieu Nov 2005 A1
20050283159 Amara Dec 2005 A1
20060052725 Santilli Mar 2006 A1
20060052878 Schmieding Mar 2006 A1
20060074421 Bickley et al. Apr 2006 A1
20060074488 Abdou Apr 2006 A1
20060074492 Frey Apr 2006 A1
20060084998 Levy et al. Apr 2006 A1
20060100715 De Villiers May 2006 A1
20060129153 Klaue et al. Jun 2006 A1
20060149258 Sousa Jul 2006 A1
20060173462 Kay et al. Aug 2006 A1
20060200151 Ducharme et al. Sep 2006 A1
20060229617 Meller et al. Oct 2006 A1
20060247787 Rydell et al. Nov 2006 A1
20070038303 Myerson et al. Feb 2007 A1
20070078518 Lavi Apr 2007 A1
20070106283 Garcia et al. May 2007 A1
20070123873 Czartoski et al. May 2007 A1
20070123993 Hassler et al. May 2007 A1
20070142920 Niemi Jun 2007 A1
20070177959 Chopp et al. Aug 2007 A1
20070185583 Branemark Aug 2007 A1
20070185584 Kaufmann et al. Aug 2007 A1
20070198018 Biedermann et al. Aug 2007 A1
20070213831 de Cubber Sep 2007 A1
20070239158 Trieu et al. Oct 2007 A1
20070293866 Stroeckel et al. Dec 2007 A1
20080039949 Meesenburg et al. Feb 2008 A1
20080051912 Hollawell Feb 2008 A1
20080086139 Bourke et al. Apr 2008 A1
20080132894 Coilard-Lavirotte et al. Jun 2008 A1
20080132958 Pech et al. Jun 2008 A1
20080154385 Trail et al. Jun 2008 A1
20080161919 Melkent Jul 2008 A1
20080177262 Augoyard et al. Jul 2008 A1
20080177291 Jensen et al. Jul 2008 A1
20080177334 Stinnette Jul 2008 A1
20080195215 Morton Aug 2008 A1
20080195219 Wiley et al. Aug 2008 A1
20080221574 Cavallazzi Sep 2008 A1
20080221697 Graser Sep 2008 A1
20080221698 Berger Sep 2008 A1
20080255618 Fisher et al. Oct 2008 A1
20080269908 Warburton Oct 2008 A1
20080294204 Chirico et al. Nov 2008 A1
20090005782 Chirico et al. Jan 2009 A1
20090012564 Chirico et al. Jan 2009 A1
20090036893 Kartalian et al. Feb 2009 A1
20090149891 Lee et al. Jun 2009 A1
20090163918 Levy et al. Jun 2009 A1
20090187219 Pachtman et al. Jul 2009 A1
20090204158 Sweeney Aug 2009 A1
20090210016 Champagne et al. Aug 2009 A1
20090216282 Blake et al. Aug 2009 A1
20090254189 Scheker Oct 2009 A1
20090254190 Gannoe et al. Oct 2009 A1
20090259316 Ginn et al. Oct 2009 A1
20100010637 Pequignot Jan 2010 A1
20100016982 Solomons Jan 2010 A1
20100023012 Voor Jan 2010 A1
20100030221 Christian et al. Feb 2010 A1
20100049244 Cohen et al. Feb 2010 A1
20100057214 Graham et al. Mar 2010 A1
20100061825 Liu et al. Mar 2010 A1
20100069913 Chirico Mar 2010 A1
20100069970 Lewis et al. Mar 2010 A1
20100121390 Kleinman May 2010 A1
20100125274 Greenhalgh et al. May 2010 A1
20100131014 Peyrot et al. May 2010 A1
20100131072 Schulte May 2010 A1
20100161068 Lindner et al. Jun 2010 A1
20100185295 Emmanuel Jul 2010 A1
20100217325 Hochschuler et al. Aug 2010 A1
20100249942 Goswami et al. Sep 2010 A1
20100256639 Tyber et al. Oct 2010 A1
20100256770 Hakansson et al. Oct 2010 A1
20100262254 Lawrence et al. Oct 2010 A1
20100274293 Terrill et al. Oct 2010 A1
20100286692 Greenhalgh et al. Nov 2010 A1
20100292799 Hansell et al. Nov 2010 A1
20100324556 Tyber et al. Dec 2010 A1
20100331893 Geist et al. Dec 2010 A1
20110004255 Weiner et al. Jan 2011 A1
20110004317 Hacking et al. Jan 2011 A1
20110066190 Schaller et al. Mar 2011 A1
20110082507 Klaue Apr 2011 A1
20110082508 Reed Apr 2011 A1
20110093017 Prasad et al. Apr 2011 A1
20110093075 Duplessis et al. Apr 2011 A1
20110093085 Morton Apr 2011 A1
20110118739 Tyber et al. May 2011 A1
20110144644 Prandi et al. Jun 2011 A1
20110144766 Kale et al. Jun 2011 A1
20110208252 Erhart Aug 2011 A1
20110257652 Roman Oct 2011 A1
20110301652 Reed et al. Dec 2011 A1
20110301653 Reed et al. Dec 2011 A1
20110306975 Kaikkonen et al. Dec 2011 A1
20110319946 Levy et al. Dec 2011 A1
20120016428 White et al. Jan 2012 A1
20120065692 Champagne et al. Mar 2012 A1
20120065738 Schulman Mar 2012 A1
20120089197 Anderson Apr 2012 A1
20120136448 Seifert et al. May 2012 A1
20120209337 Weinstein Aug 2012 A1
20120259419 Brown et al. Oct 2012 A1
20120271362 Martineau et al. Oct 2012 A1
20120323241 McClellan et al. Dec 2012 A1
20130030475 Weiner et al. Jan 2013 A1
20130053975 Reed et al. Feb 2013 A1
20130060295 Reed et al. Mar 2013 A1
20130066383 Anderson et al. Mar 2013 A1
20130066435 Averous et al. Mar 2013 A1
20130079776 Zwirkoski et al. Mar 2013 A1
20130090655 Tontz Apr 2013 A1
20130096634 Suh Apr 2013 A1
20130123862 Anderson et al. May 2013 A1
20130131822 Lewis et al. May 2013 A1
20130150965 Taylor et al. Jun 2013 A1
20130190761 Prandi et al. Jul 2013 A1
20130211451 Wales et al. Aug 2013 A1
20130226191 Thoren et al. Aug 2013 A1
20130253597 Augoyard et al. Sep 2013 A1
20130274814 Weiner et al. Oct 2013 A1
20130317559 Leavitts et al. Nov 2013 A1
20130317599 Michal et al. Nov 2013 A1
20130325138 Graham Dec 2013 A1
20140018930 Oster Jan 2014 A1
20140025125 Sack et al. Jan 2014 A1
20140052196 McGinley et al. Feb 2014 A1
20140107713 Pech et al. Apr 2014 A1
20140135768 Roman May 2014 A1
20140142715 McCormick May 2014 A1
20140180428 McCormick Jun 2014 A1
20140188179 McCormick Jul 2014 A1
20140188237 McCormick et al. Jul 2014 A1
20140188239 Cummings Jul 2014 A1
20140257289 Kecman et al. Sep 2014 A1
20140276825 Brown et al. Sep 2014 A1
20140277185 Boileau et al. Sep 2014 A1
20140277186 Granberry et al. Sep 2014 A1
20150012098 Eastlack et al. Jan 2015 A1
20150018954 Loebl et al. Jan 2015 A1
20150073413 Palmer et al. Mar 2015 A1
20150088136 Vitek et al. Mar 2015 A1
20150088266 Sander et al. Mar 2015 A1
20150094778 McCormick et al. Apr 2015 A1
20150112342 Penzimer et al. Apr 2015 A1
20150141994 Cheney et al. May 2015 A1
20150142066 Shemwell et al. May 2015 A1
20150164563 Lewis et al. Jun 2015 A1
20150223848 McCormick et al. Aug 2015 A1
20150223849 McCormick et al. Aug 2015 A1
20150342655 Reed et al. Dec 2015 A1
Foreign Referenced Citations (79)
Number Date Country
1047025 Nov 1990 CN
201085677 Jul 2008 CN
0127994 Dec 1984 EP
0340159 Nov 1989 EP
0409364 Jan 1991 EP
0545830 Jun 1993 EP
0551846 Jul 1993 EP
0611557 Aug 1994 EP
0738502 Oct 1996 EP
880950 Dec 1998 EP
1300122 Apr 2003 EP
1825826 Aug 2007 EP
1870050 Dec 2007 EP
1708653 Sep 2009 EP
2156795 Feb 2010 EP
1923012 Jun 2010 EP
1868536 Nov 2010 EP
2275055 May 2012 EP
2221025 Dec 2012 EP
2221026 Mar 2013 EP
2564799 Mar 2013 EP
2774556 Sep 2014 EP
736058 Nov 1932 FR
1036978 Sep 1953 FR
2603794 Mar 1988 FR
2605878 May 1988 FR
2628312 Sep 1989 FR
2645735 Oct 1990 FR
2651119 Mar 1991 FR
2663838 Jan 1993 FR
2694696 Feb 1994 FR
2725126 Apr 1996 FR
2743490 Jul 1997 FR
2754702 Apr 1998 FR
2783702 Mar 2000 FR
2787313 Jun 2000 FR
2794019 Dec 2000 FR
2801189 May 2001 FR
2808182 Oct 2002 FR
2846545 May 2004 FR
2728779 Jul 2005 FR
2884406 Oct 2006 FR
2927529 Aug 2009 FR
2935601 Mar 2010 FR
140983 Apr 1920 GB
2119655 Nov 1983 GB
2227540 Aug 1990 GB
2336415 Oct 1999 GB
2430625 Apr 2007 GB
S53-128181 Nov 1978 JP
60145133 Jul 1985 JP
H07-500520 Jan 1995 JP
07303662 Nov 1995 JP
2004535249 Nov 2004 JP
2007530194 Nov 2007 JP
2008-188411 Aug 2008 JP
2009-160399 Jul 2009 JP
2010-046481 Mar 2010 JP
2011-502584 Jan 2011 JP
2011-525229 Sep 2011 JP
1152582 Apr 1985 SU
WO 9217122 Oct 1992 WO
WO 9641596 Dec 1996 WO
WO 9817189 Apr 1998 WO
WO 9847449 Oct 1998 WO
WO 9921515 May 1999 WO
WO 0180751 Nov 2001 WO
WO 2002034107 May 2002 WO
WO 2005063149 Jul 2005 WO
WO 2005094706 Oct 2005 WO
WO 2005104961 Nov 2005 WO
WO 2006109004 Oct 2006 WO
WO 2006103598 Oct 2006 WO
WO 2007048038 Apr 2007 WO
WO 2007135322 Nov 2007 WO
WO 2009155577 Dec 2009 WO
WO 2013096746 Jun 2013 WO
WO 2013131974 Sep 2013 WO
WO 2014165123 Oct 2014 WO
Non-Patent Literature Citations (13)
Entry
Brochure MKT 016 A: iFuse HT Hammertoe Correction Implant, OrthoPro LLC, 2 pages, undated.
Brochure p/n 030-1788 Rev A: ExtremiFuse Hammertoe Fixation System, OsteoMED Smalll Bone Orthopedics, 6 pages, undated.
Brochure 900-01-008 Rev C: Hammer Toe Implant System Instructions for Use, Trilliant Surgical Ltd, 2 pages, undated.
Japanese Patent Office, Office Action corresponding to foreign counterpart Japanese Patent Application No. 2013-265478, dated Jan. 13, 2015, 3pgs.
Bensmann, et al., “Nickel-titanium Osteosynthesis Clips,” Reprint from Medical Focus, 1983.
Besselink, Sachdeva, “Applications of Shape Memory Effects,” Memory Metal Holland, Memory Medical Systems, Publication Date Unknown.
Dai, K.R., et al., “Treatment of Intra-Articular Fractures with Shape Memory Compression Staples,” Injury, (1993) 24, (IO), 651-655.
Haasters, Dr. J., et al. , “The Use of Ni—Ti as an Implant Material in Orthopedics”, pp. 426-444.
Kuo, M.D., et al., “The Use of Nickel-Titanium Alloy in Orthopedic Surgery in China,” Orthopedics, Jan. 1989, vol. 12/No. 1.
Lu, M.D., Shibi,“Medical Applications of Ni—Ti Alloys in China,” pp. 445-451.
Ricart, “The Use of a Memory Shape Staple in Cervical Anterior Fusion,” Proceedings of the Second International Conference on Shape Memory and Superelastic Technologies, Asilomar Conference Center, Pacific Grove, CA, USA, Mar. 2-6, 1997.
Ricart, “The Use of a Memory-Shaple Staple in Cervical Anterior Fusion,” in Shape Memory Implants, Springer-Verlag Berlin Heidelberg, 2000.
Tang, Dai, Chen ,“Application of a Ni—Ti Staple in the Metatarsal Osteotomy,” Bio-Medical Materials and Engineering 6, (1996), 307-312, IOS Press.
Related Publications (1)
Number Date Country
20170042691 A1 Feb 2017 US
Provisional Applications (1)
Number Date Country
61747429 Dec 2012 US
Divisions (1)
Number Date Country
Parent 13839573 Mar 2013 US
Child 14560265 US
Continuations (1)
Number Date Country
Parent 14560265 Dec 2014 US
Child 15337275 US